-20℃ 3 years powder
-80℃ 2 years in solvent
USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | 248.00 | |
10 mg | In stock | 346.00 | |
50 mg | In stock | 834.00 | |
100 mg | In stock | inquiry | |
200 mg | In stock | inquiry | |
1 mL * 10 mM (in DMSO) | In stock | 273.00 |
Description | USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity. |
Targets&IC50 | CXCR4, |
Appearance | solid |
Molecular Weight | 422.57 |
Formula | C24H34N6O |
CAS No. | 1373268-67-7 |
-20℃ 3 years powder
-80℃ 2 years in solvent
DMSO: 24 mg/mL (59.79 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.